IP Library Granted Patent US 9,580,692
Granted Patent B2
US 9,580,692 · App. 14/380,477 · Granted Feb 28, 2017

Method for endotoxin removal

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,580,692
App. No.
14/380,477
Granted
Feb 28, 2017
Kind
B2
Abstract

The present invention relates to a method for endotoxin removal from a sample comprising the following steps: combining the sample comprising one or more target molecule(s) with a chromatography media comprising beads having an inner porous core functionalized with ligands capable of binding endotoxin and an outer porous layer without functional groups and a pore size small enough to exclude the target molecule from the inner core; and collecting the sample from the media, wherein the sample comprises an endotoxin level which is at least 75% less, preferably 90% less, than before the removal and the yield of the target molecule is at least 75%.

Claims (13)

1. A method for endotoxin removal from a sample comprising the following steps:

combining the sample comprising one or more target molecule(s) and an endotoxin with a chromatography media comprising beads having an inner porous core functionalized with ligands capable of binding the endotoxin and a 5-7 μm thick outer porous layer without functional groups and a pore size small enough to exclude the target molecule from the inner core, wherein the exclusion limit of said outer porous layer is about 700 kDa; and

collecting the sample from the media, wherein the sample comprises an endotoxin level which is at least 75% less, preferably 90% less, than before the removal and the yield of the target molecule is at least 75%.

2. Method according to claim 1 , wherein the chromatography media is packed in a column and the sample is collected in the flow-through.

3. The method of claim 1 , wherein the target molecule is a virus.

4. The method of claim 1 , wherein the core is functionalized with ligands capable of binding endotoxins such as primary, secondary, tertiary or quaternary amines.

5. The method of claim 4 , wherein the ligands are multimodal amines containing a hydrophobic moiety.

6. The method of claim 5 , wherein the hydrophobic moiety consists of an aliphatic or aromatic hydrocarbon with 3-20 carbon atoms, preferably between 4 and 18 carbon atoms.

7. The method of claim 6 , wherein the ligand is octylamine.

8. The method of claim 1 , wherein the chromatography media is made of a natural or synthetic polymer.

9. The method of claim 1 , wherein the sample is a supernatant from a cell culture producing recombinant protein or virus.

10. The method of claim 1 , wherein the chromatography media is made of a natural polymer.

11. The method of claim 1 , wherein the chromatography media is made of agarose.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2014
From: ADIELSSON, PATRIK; SODERMAN, TOBIAS E.; AKERBLOM, ANNA
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 033590/0704 →